- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03036683
Transcranial Direct Current Stimulation in Offenders
October 17, 2022 updated by: Olivia Choy
The Effect of Transcranial Direct Current Stimulation on Risk-taking and Aggression in Offenders
This study investigates the effect of upregulating prefrontal cortex activity on risk-taking, and antisocial and aggressive behavior in violent offenders.
In the double-blind, randomized controlled trial, using a within-subject crossover design, each participant will undergo anodal transcranial direct current stimulation of the right dorsolateral prefrontal cortex and sham stimulation.
After each stimulation session, neural activity and behavioral responses to tasks assessing risk-taking and aggressive behavior will be recorded.
The effect of tDCS on violent offenders will also be assessed in comparison to age and gender-matched healthy controls.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aachen, Germany, 52074
- Uniklinik RWTH Aachen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Between 18 and 50 years of age
- Able to understand the nature of the study and give informed consent
- Individuals in the violent offender group must have a record of repeated violent criminal offending (at least 2 felonies).
- Individuals in the violent offender group must have been convicted solely due to crimes involving violence motivated by impulsive aggression.
Exclusion Criteria:
- Presence of any contraindications for functional magnetic resonance imaging (fMRI)
- History of significant medical illness
- History of any neurological condition
- Diagnosis of schizophrenia
- History of epilepsy
- Head injury
- Mental retardation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Anodal stimulation
Participants in the active stimulation group will undergo anodal transcranial direct current stimulation (tDCS).
tDCS will be delivered by a battery-driven, constant-current stimulator connected to two saline-soaked surface sponge electrodes.
An anodal electrode (25cm2) will be placed over the right dorsolateral prefrontal cortex and one cathodal electrode (100cm2) will be placed over the left supraorbital area at least 5cm from the anode.
Scalp electrodes will be positioned according to the 10-20 EEG international system.
A current of 2mA will be applied for 20 minutes and the current will be ramped up and down over 20 seconds at the beginning and end of the stimulation period.
|
Transcranial direct current stimulation will be administered for 20 minutes using a CE approved stimulator (NeuroConn, Ilmenau, Germany).
|
SHAM_COMPARATOR: Sham stimulation
The sham tDCS condition will involve the same placement of the electrodes, current intensity, and ramp-up/down time as the active tDCS condition, but stimulation will only last for 30 seconds.
|
The same device will be used as in the active stimulation group, but stimulation will be terminated after 30 seconds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of balloon pumps in the Balloon Analogue Risk Task after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
The number of balloon pumps, measured by the number of times subjects press a button to pump up a computerized balloon over 60 trials, will be assessed.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Neural activity during Balloon Analogue Risk Task after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
Functional brain activity and connectivity will be assessed using functional magnetic resonance imaging.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Aggressive behavior after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
This will be assessed according to performance on the violent video game, Carmageddon: TDR 2000 (Klasen et al., 2013; Torus Games, Bayswater, Australia, 2000) in comparison to a modified non-violent version of the game.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Neural activity during aggression task after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
Functional brain activity and connectivity during participation in the video game will be assessed using functional magnetic resonance imaging.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Antisocial behavior inclinations after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act.
Participants will respond to the likelihood that they would commit the act in the scenario according to a 10-point Likert scale.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with adverse events
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
The number of participants reporting the experience of sensations resulting from tDCS will be recorded.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Ratings of guilt or shame regarding antisocial acts after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act.
Participants will respond to the likelihood that they would feel a sense of guilt or shame according to a 10-point Likert scale.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Ratings of moral wrongfulness regarding antisocial acts after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
|
This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act.
Participants will rate the moral wrongfulness of the acts according to a 10-point Likert scale.
|
Within 1 hour after the 20-minute tDCS or sham session ends
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ute Habel, PhD, RWTH Aachen University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2017
Primary Completion (ACTUAL)
June 1, 2021
Study Completion (ACTUAL)
June 1, 2022
Study Registration Dates
First Submitted
January 26, 2017
First Submitted That Met QC Criteria
January 26, 2017
First Posted (ESTIMATE)
January 30, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 18, 2022
Last Update Submitted That Met QC Criteria
October 17, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK 341/16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aggression
-
University of KonstanzCompletedAppetitive AggressionGermany
-
New York State Psychiatric InstituteCompletedIrritable AggressionUnited States
-
Boston UniversityU.S. Department of JusticeCompletedSexual Aggression | Offensive Aggression | Dating Violence Perpetration and VictimizationUnited States
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive AggressionUnited States
-
Weill Medical College of Cornell UniversityGreen Chimneys Residential Treatment Center, Brewster, NYCompletedChildhood AggressionUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Arizona State UniversityCompletedHeavy Drinking | Sexual AggressionUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive Aggression Comorbid With ADHDUnited Kingdom
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityNot yet recruitingAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityCompletedAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
Clinical Trials on Transcranial direct current stimulation
-
Federal University of ParaíbaCompleted
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University of Campinas, BrazilUnknownEpilepsy IntractableBrazil
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
Dina Hatem ElhammadyUnknown
-
University of Texas Rio Grande ValleyRecruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Federal University of ParaíbaUnknown
-
University of CalgaryAlberta Health servicesRecruitingCervicogenic HeadacheCanada
-
Universidade Federal do Rio Grande do NorteNot yet recruitingLow Back Pain | Transcranial Direct Current Stimulation
-
Nanyang Technological UniversityActive, not recruiting